Results 111 to 120 of about 199,064 (179)
Targeted Protein Degradation: From Molecular Mechanisms to Emerging Therapeutic Strategies
Graphical overview of targeted protein degradation: mechanisms, molecular determinants, delivery strategies, and therapeutic development. This graphical abstract summarizes the major degradation pathways involved in targeted protein degradation, including the ubiquitin–proteasome system, endocytosis–lysosome pathway, and autophagy‐dependent degradation.
Huaijuan Guo +8 more
wiley +1 more source
Pleiotropic Roles of FBXO11 in Tumorigenesis: Implications for Targeted Therapy
This complex comprises of scaffold CUL1, SKP1, RBX1 and FBXO11 receptor. The substrate is phosphorylated by specific kinase enzyme and recognized by the substrate recognition domain. FBXO11 targets numerous substrates for ubiquitination and degradation, FBXO11 substrates mainly include Snail, ZEB1, p53, BCL6, CDT2, CIITA, Cdc25a, hnRNPA2B1, SAMD1 and ...
Yuqi Zhang +6 more
wiley +1 more source
The ageing human B cell repertoire: A failure of selection? [PDF]
B cells undergo a number of different developmental stages, from initial formation of their B cell receptor (BCR) genes to differentiation into antibody-secreting plasma cells.
Dunn-Walters, Deborah Kay +1 more
core +1 more source
Adult ascidians are capable of regenerating their entire brains following injury, and glycosaminoglycans have been shown to either promote or inhibit neuritogenesis. In this study, dermatan 2,6‐disulfate (D2,6S) was identified as the predominant complex carbohydrate in the ascidian brain.
Taynan Motta Portal +5 more
wiley +1 more source
High-throughput sequencing of BCR heavy-chain (BCR-H) CDR3 regions was performed in 22 children, including 9 healthy controls and 13 patients with KD, of whom 9 had no CAL and 4 had CAL.
openaire +3 more sources
Abstract Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease. It affects over 2 million people worldwide but has historically been challenging to diagnose, categorize, and treat. MS has an autoimmune component that involves the production of B-cell receptors (BCRs) and immunoglobulins (Igs) that are associated with ...
Graham C. Peet +4 more
openaire +2 more sources
In Ph(+) chronic myeloid leukemia (CML), the constitutively active Bcr-Abl kinase leads to the up-regulation and activation of multiple genes, which may subsequently result in the expression of leukemia-associated antigens. In this study, we investigated
Scheich, F;Duyster, J;Peschel, C;Bernhard, H
core +2 more sources
Circulating B-Cell Receptor (BCR) Repertoire Diversity as a Biomarker of Immunotherapy Response
The immunotherapy of cancer has revolutionized the treatment of oncologic cancer, but the patient response has been very heterogeneous and this has greatly raised the need to develop strong, minimally invasive, biomarkers that predict and monitor the reaction to the treatment.
openaire +1 more source
B-cell immune repertoire analysis of autoimmune neurological syndromes with anti-GAD65 antibodies
BackgroundAutoimmune neurological syndromes (AINS) associated with anti-GAD65 antibodies encompass a spectrum of disorders, including limbic encephalitis (LE), stiff-person syndrome (SPS), and cerebellar ataxia (CA).
Tianya Dong +8 more
doaj +1 more source
Molecular characterization of the IgE serological repertoire in pediatric peanut allergy 2267488
Introduction Though recent strides in peanut allergy prevention have changed the clinical thinking about pediatric treatment, the antibodies responsible for severe allergic reactions, IgE, remain poorly understood, especially at the ...
Jeffrey Marchioni +4 more
core +1 more source

